Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease

Detalles Bibliográficos
Autores principales: Chen, Shuchun, Yu, Seong-Jin, Li, Yazhou, Lecca, Daniela, Glotfelty, Elliot, Kim, Hee Kyung, Choi, Ho-Il, Hoffer, Barry J., Greig, Nigel H., Kim, Dong Seok, Wang, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135809/
https://www.ncbi.nlm.nih.gov/pubmed/30209317
http://dx.doi.org/10.1038/s41598-018-31455-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135809/
https://www.ncbi.nlm.nih.gov/pubmed/30209317
http://dx.doi.org/10.1038/s41598-018-31455-w

Ejemplares similares